Concluding comments
The study of pharmacogenetics and ecogenetics among different individuals and populations offers an unique opportunity to understand multiple, simultaneously occurring interactions between genes and the environment, and the subsequent phenotypic expression of heritable characters. Incorporation of appropiate ecogenetic diagnostic services into the general genetic services may be useful for public health monitoring in the prevention of occupational disease.
The modern methods of molecular biochemistry will allow the characterization of hereditary traits affecting drug metabolism at the DNA level. Gene identification, isolation and cloning will help to determine whether gene duplication and other such events have taken place leading to species differences in the metabolism of drugs and xenobiotics.
Similar content being viewed by others
References
Agarwal, D. P., Schwenkenbecher, S., Srivastava, L. M., and Goedde, H. W., Spektrophotometrische Bestimmungsmethode für Serumcholinesterase (EC 3.1.1.8) — Varianten mit Succinylbischolin als Substrat. Z. klin. Chem. klin. Biochem.13 (1975) 133–135.
Agarwal, D. P., Srivastava, L. M., and Goedde, H. W., A note on suxamethonium sensitivity and serum cholinesterase-variants. Hum. Genet.32 (1976) 85–88.
Agarwal, D. P., and Goedde, H. W., Thin-layer chromatographic separation of14-C-labelled succinyldicholine, succinyl-monocholine and choline. J. Chromat.121 (1976) 170–172.
Agarwal, D. P., Harada, S., and Goedde, H. W., Racial differences in biological sensitivity to ethanol: The role of alcohol dehydrogenase and aldehyde dehydrogenase isozymes. Alcohol. clin. expl Res.5 (1981) 12–16.
Agarwal, D. P., and Goedde, H. W., Alkohol metabolisierende Enzyme: Alkoholunverträglichkeit und Alkoholkrankheit, in: Klinische Genetik des Alkoholismus, pp. 65–89. Ed. K. D. Zang. Kohlhammer 1984.
Altland, K., and Goedde, H. W., Heterogeneity in the silent gene phenotype of pseudocholinesterase of human serum. Biochem. Genet.4 (1970) 321–338.
Andreasen, P. B., Frøland, A., Skovsted, L., Andersen, S. A., and Hauge, M., Diphenylhydantoin half-life in man and its inhibition by phenylbutazone. The role of genetic factors. Acta med. scand.193 (1973) 561–564.
Azad Khan, A. K., Nurazzaman, M., and Truelove, S. C., The effect of the acetylator phenotype on the metabolism of sulphasalazine in man. J. med. Genet.20 (1983) 30–36.
Bertilson, L., Dengler, H. J., Eichelbaum, M., and Schulz, H. U., Pharmacogenetic Covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine. Eur. J. Chim. Pharmac.17 (1980) 153–155.
Brown, S. A., Kalow, W., Pilz, W., Whittaker, M., and Woronic, C. L., The plasma cholinesterases: A new prospective. Adv. clin. Chem.22 (1982) 1–123.
Carro-Ciampi, G., Kadar, D., and Kalow, W., Distribution of serum paraoxon hydrolyzing activities in a Canadian population. Can. J. Physiol. Pharmac.59 (1981) 904–907.
Chakraborty, R., Constans, J., and Majundar, P. P., Transmission of the PiZ allele for α1-antitrypsin deficiency: population genetic considerations. Hum. Genet.62 (1982) 193–197.
Dam, M., Larsen, L., and Christiansen, J., Phenytoin: Ethnic differences in plasma level and clearance, in: Antiepileptic Drug Monitoring. pp. 73–80. Eds H. Meinardi, C. Gardner-Thorpe, D. Janz and C. E. Pippenger. Pittman Medical Publishing, Kent, England 1977.
Drayer, D. E., and Reidenberger, M. M., Clinical consequences of polymorphic acetylation of basic drugs. Clin. Pharmac. Ther.22 (1977) 251–258.
Eckerson, H. W., Wypte, C. M., and La Du, B. N., The human serum paraoxonase/arylesterase polymorphism. Am. J. hum. Genet.35 (1983) 1126–1138.
Eichelbaum, M., Spannbrucker, N., Steincke, B., and Dengler, H. J., Defective N-oxidation of sparteine in man — A new pharmacogenetic defect. Eur. J. clin. Pharmac.16 (1979) 183–187.
Eichelbaum, M., Bertilsson, L., Säwe, J., and Zekorn, C., Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities. Clin. Pharmac. Ther.31 (1982) 184–186.
Evans, D. A. P., The association of the slow acetylator phenotype with bladder cancer. J. med. Genet.20 (1983) 330–333.
Evans, D. A. P., Survey of the human acetylator polymorphism in spontaneous disorders. J. med. Genet.21 (1984) 243–253.
Fagerhol, M. K., and Cox, D. W., The Pipolymorphism: Genetic, biochemical and clinical aspects of human α1-antitrypsin, in: Advances in Human Genetics, vol. 11, pp. 1–62. Eds H. Harris and K. Hirschkorn. Plenum Press, New York 1981.
Faris, J. J., and Jones, B. M., Ethanol metabolism in male American Indians and Whites. Alcoholism2 (1978) 77–82.
Fenna, D. W., Mix, L., and Schaefer, O., Ethanol metabolism in various racial groups. Can. med. Ass. J.105 (1971) 472–475.
Geldmacher-v. Mallinckrodt, M., Lindorf, H. H., Petenyi, M., Glügel, M., Fischer, T., and Hiller, T., Genetisch determinierter Polymorphismus der menschlichen Serum-Paraoxonase (EC 3.1.1.2). Hum. Genet.17 (1973) 331–335.
Geldmacher-v. Mallinckrodt, M., Hommel, G., and Dumbach, I., On the genetics of the human serum paraoxonase (EC 3.1.1.2). Hum. Genet.50 (1979) 313–326.
Geldmacher-v. Mallinckrodt, M., Diepgen, T. L., Duhme, C., and Hommel, G., A study of the polymorphism and ethnic distribution differences of human serum paraoxonase. Am. J. phys. Anthrop.62 (1983) 235–241.
Goedde, H. W., Altland, K., and Scholler, K. L., Therapie der durch genetisch bedingte Pseudocholinesterase-Varianten verursachten verlängerten Apnoe nach Succinyldicholin. Med. Klin.62 (1967) 1631.
Goedde, H. W., Doenicke, A., and Altland, K., Pseudocholinesterasen: Pharmakogenetik, Biochemie, Klinik. Springer Verlag, Berlin 1967.
Goedde, H. W., Altland, K., and Schloot, W., Therapy of a prolonged apnea after suxamethonium with purified pseudocholinesterase: New data on kinetics of the hydrolysis of succinyldicholine and succinylmonocholine and on N-acetyl-transferase-polymorphism. Ann. N.Y. Acad. Sci.151 (1968) 742–752.
Goedde, H. W., and Altland, K., Suxamethonium Sensitivity. Ann. N.Y. Acad. Sci.179 (1971) 695–703.
Goedde, H. W., Genetic aspects in the metabolism of drugs and environmental agents. 4e Coll. Int. Biol. Prosp. Annls Biol. clin.36 (1978) 149–334.
Goedde, H. W., and Agarwal, D. P., Pseudocholinesterase variation. Hum. Genet.1 (1978) 45–55.
Goedde, H. W., Agarwal, D. P., and Benkmann, H.-G., Pharmacogenetics of cholinesterase: New variants and suxamethonium sensitivity. Ärztl. Lab.25 (1979) 219–224.
Goedde, H. W., Harada, S., and Agarwal, D. P., Racial differences in alcohol sensitivity: a new hypothesis. Hum. Genet.51 (1979) 331–334.
Goedde, H. W., Pharmakogenetik und Ökogenetik, Wissenschaftl. Tabellen Geigy, Teilband Hämatologie und Humangenetik8 (1979) 288–294.
Goedde, H. W., Agarwal, D. P., and Harada, S., The role of alcohol dehydrogenase and aldehyde dehydrogenase isozymes in alcohol metabolism, alcohol sensitivity and alcoholism, in: Isozymes, Current Topics in Biological and Medical Research, vol. 8, pp. 175–193. Alan R. Liss, Inc., New York 1983.
Goedde, H. W., Agarwal, D. P., Harada, S., Meier-Tackmann, D., Du Ruofu, Bienzle, U., Kroeger, A., and Hussein, L., Population genetic studies on aldehyde dehydrogenase isozyme deficiency and alcohol sensitivity. Am. J. hum. Genet.35 (1983) 769–772.
Goedde, H. W., Rothhammer, F., Benkmann, H.-G., and Bogdanski, P., Ecogenetic studies in Atacameno Indians. Hum. Genet.67 (1984) 343–346.
Goedde, H. W., Agarwal, D. P., Eckey, R., and Harada, S., Population genetic and family studies on aldehyde dehydrogenase deficiency and alcohol sensitivity. Alcohol2 (1985) 383–390.
Greenfield, N. J., and Pietruszko, R., Two aldehyde dehydrogenases from human liver: isolation via affinity chromatography and characterization of the isozymes. Biochem. biophys. Acta483 (1977) 35–45.
Günther, H., Döhnhardt, A., Altland, K., Jensen, M., and Goedde, H. W., Therapie einer schweren Alkylphosphatintoxikation. Kasuistik der Vergiftung und Anwendung eines gereinigten menschlichen Cholinesterasepräparates. Med. Klin.21 (1971) 785–788.
Hanna, J. M., Metabolic responses of Chinese, Japanese and Europeans to alcohol. Alcoholism2 (1978) 89–92.
Harada, S., Misawa, S., Agarwal, D. P., and Goedde, H. W., Liver alcohol dehydrogenase and aldehyde dehydrogenase in the Japanese: isozyme variation and its possible role in alcohol intoxication. Am. J. hum. Genet.32 (1980) 8–15.
Harada, S., Agarwal, D. P., and Goedde, H. W., Electrophoresis and biochemical studies of human aldehyde dehydrogenase isozymes in various tissues. Life Sci.26 (1980) 1771–1780.
Harada, S., Agarwal, D. P., and Goedde, H. W., Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancetii (1981) 892.
Harada, S., Agarwal, D. P., Goedde, H. W., Tagaki, S., and Ishikawa, B., Possible protective role against alcoholism for aldehyde dehydrogenase isozyme deficiency in Japan. Lancetii (1982) 827.
Harris, H., and Whittaker, M., Differential inhibition of human serum cholinesterase with fluoride: Recognition of two phenotypes. Nature191 (1961) 496–498.
Idle, J. R., and Smith, R. L., Polymorphisms of oxidation at carbon centers of drugs and their clinical significance. Drug Metab. Rev.9 (1979) 301–317.
Impraim, C., Wang, G., and Yoshida, A., Structural mutation in a major human aldehyde dehydrogenase gene results in loss of enzyme activity. Am. J. hum. Genet.34 (1982) 837–841.
Inaba, T., Uchino, H., Kadar, D., and Kalow, W., Antipyrine metabolites in two populations. Res. Commun. Chem. Path. Pharmac.32 (1981) 235–244.
Kahn, A., G6PD Variants. Hum. Genet., suppl. 1 (1978) 37–44.
Kalow, W., and Genest, K., A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers. Can. J. Biochem.35 (1957) 339–345.
Kalow, W., Tang, B. K., Kadar, D., Endrenyi, L., and Chan, F.-Y., A method for studying drug metabolism in populations: Racial differences in amobarbital metabolism. Clin. Pharmac. Ther.26 (1979) 766–776.
Kalow, W., Otton, S. V., Kadar, D., Endrenyi, L., and Inaba, T., Ethnic differences in drug metabolism: Debrisoquine 4-hydroxylation in Caucasian and Orientals. Can. J. Physiol. Pharmac.58 (1980) 1142–1144.
Kalow, W., Ethnic differences in drug metabolism. Clin. Pharmacokinet.7 (1982) 373–400.
Kueppers, F., Inherited differences in alpha1-antitrypsin, in: Genetic Determinants of Pulmonary Disease, pp. 23–74. Ed. S. Litwin Marcel Dekker, New York 1978.
Kueppers, F., The effect of smoking on the development of emphysema in alpha1-antitrypsin deficiency, in: The Role of Genetic Predisposition in Responses to Chemical Exposures. Eds G. S. Omenn and H. Gelboin. Banbury Conference. Cold Spring Harbor Laboratory, New York, 1984.
La Du B. N., Drug metabolism and pharmacogenetics, Drug Metab. Dispos.11 (1983) 283–285.
Liddell, J., Lehmann, H., and Silk, E., A silent gene in pseudocholinesterase polymorphism. Nature198 (1963) 1090.
Mittman, C., The PiMZ phenotype: Is it a significant risk factor for the development of chronic obstructive lung disease? Am. Rev. Respir. Dis.118 (1978) 649–652.
Mizoi, Y., Kogame, M., Adachi, J., Okado, T., and Fukunaga, T., Polymorphism of alcohol-metabolizing enzymes and its correlation with blood levels of acetaldehyde and catecholamines after alcohol intake in Japanese. Int. Titisee-Symp. on Alcohol Metabolism in Humans and its Enzymes. Alcohol. clin. expl Res.6 (1982) 426–438.
Morikawa, Y., Matsusaka, B., Kuratsune, M., Tsukamoto, S. and Mikisumi, S., Plethsymographic Study of Effects of Alcohol Nature220 (1968) 186–187.
Nebert, D. W., Eisen, H. J., Negishi, M., Lang, M. A., Hjelmeland, L. M., and Okey, A. B., Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities. A. Rev. Pharmac. Toxic.21 (1981) 431–462.
Ortigoza-Ferado, J., Richter, R. J., Hornung, S. K., Motulsky, A. G., and Furlong, C. E., Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin. Am. J. hum. Genet.36 (1984) 295–305.
Playfer, J. R. Eze, L. C., Bullen, M. F., and Evans, D. A. P., Genetic polymorphism and interethnic variability of plasma paraoxonase activity. J. med. Genet.13 (1976) 337–342.
Proppoing, P., Genetic control of ethanol action on the central nervous system. An EEG study in twins. Hum. Genet.35 (1977) 309–334.
Propping, P., Krüger, J., and Janak, A., Effect of alcohol on genetically determined variant of the normal electro-encephalogram. Psychiat. Res.2 (1980) 85–98.
Propping, P., Krüger, J., and Mark, N., Genetic disposition to alcoholism. An EEG study in alcoholics and their relatives. Hum. Genet.59 (1981) 51–59.
Reed, T. E., Kalant, H., Gibbins, T., Kapur, B. M., and Rankin, J. G., Alcohol and acetalhdehyde metabolism in Caucasians, Chinese and Amerinds. Can. med. Ass. J.115 (1976) 851–855.
Reed, T. E., Racial comparisons of alcohol metabolism: Background, problems and results. Alcohol clin. expl Res.2 (1978) 83–87.
Schaefer, J. M., Alcohol metabolism and sensitivity among the Reddis of South India. Alcohol. clin. expl Res.2 (1978) 61–69.
Schwitters, S. Y., Johnson R. C., Johnson, S. B., and Ahren, F. M., Familial resemblances in flushing following alcohol use. Behav. Genet.12 (1982) 349–352.
Sloan, T. P., Lancaster, R., Sha, R. P., Idle, J. R., and Smith, R. L., Genetically determined oxidation capacity and the disposition of debrisoquine. Br. J. clin. Pharmac.15 (1983) 443–450.
Srivastava, L. M., Benkmann, H.-G., and Goedde, H. W., Review on genetic traits in Europeans, middle East Orientals and Negroes: Serum Proteins. Ird. J. phys. Antroph. hum Genet.3 (1977) 85–140.
Stamatoyannopoulos, G., Chen, S. H., and Fukui, F., Liver alcohol dehydrogenase in Japanese. High population frequency of atypical form and its possible role in alcohol sensitivity. Am. J. hum. Genet.27 (1975) 789–796.
Thompson, J. C., and Whittaker, M., A study of the pseudocholinesterase in 78 cases of apnoe following suxamethonium. Acta genet. (Basel)16 (1966) 209.
Vessel, E. S., Pharmacogenetics: Multiple interactions between genes and environment as determinants of drug response. Am. J. Med.66 (1979) 183–187.
Vessel, E. S., Advances in Pharmacogenetics, in: Progress in Medical Genetics, vol. IX, pp. 291–367. Eds A. E. Steinberg and A. E. Bearns, 1973.
Weber, W. W., Hein, D. W., Litwin W., and Lower, G. M. Jr, Relationship of acetylator status to isoniazide toxicity, lupus erythematosus and bladder cancer. Fedn Proc.42 (1983) 3086–3097.
Weber, W. W., Acetylation pharmacogenetics: experimental models for human toxicity. Fedn Proc.43 (1984) 2332–2337.
Wilson, J. R., McClearn, G. E., and Johnson, R. C., Ethnic variation in the use and effects of alcohol. Drug Alcohol Dep.3 (1978) 147–151.
Wolff, P. H., Ethnic differences in alcohol sensitivity. Science175 (1972) 449–450.
Wolff, P. H. Vasomotor sensitivity to alcohol in diverse Mongoloids populations, Am. J. hum. Genet25 (1973) 193–199.
Yamamoto, K., Huang, I.-Yih, Münsch, H., Yoshida, A., Goedde, H. W., and Agarwal, D. P., Amino acid sequence of the active site of human pseudocholinesterase. Biochem. Genet.21 (1983) 135–145.
Yuasa, I., Suenage, K., Gotok, Y., Ito, K., Yokoyama, N., and Okada, K., PI (alpha1-antitrypsin) polymorphism in the Japanese: Confirmation of PIM4 and description of new PI variants. Hum. Genet.67 (1984) 209–212.
Zeiner, A. R., Parades, A., and Christensen, C. H., The role of acetaldehyde in mediating reactivity to an acute dose of ethanol among different racial groups. Alcohol. clin. expl Res.3 (1979) 11–18.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Agarwal, D.P., Goedde, H.W. Pharmacogenetics and ecogenetics. Experientia 42, 1148–1154 (1986). https://doi.org/10.1007/BF01941289
Issue Date:
DOI: https://doi.org/10.1007/BF01941289